Abstract:OBJECTIVE To construct the expression vector pLCK-CD69-IRES-EGFP that contains mouse cell surface activation protein CD69 and enhanced green fluorescent protein(EGFP),and to generate CD69 transgenic mice based on this vector. METHODS First, RNA was extracted from mouse lung tissue and cDNA was synthesized via reverse transcription. PCR primer was designed through the PubMed searching, then mouse CD69 DNA fragment was amplified with PCR. Second, this DNA fragment was subcloned to the pInsulater-LCK-IRES-EGFP plasmid and constructed the transgenic vector after the verification of nucleotide sequence. Third, the expression vector was then transfected into 293 T cells and its expression in 293 T cells was observed under fluorescence microscope. Last, microinjection was performed to transfer the expression vector pLCK-CD69-IRES-EGFP into fertilized eggs, which were implanted into pseudo-pregnant recipient mice. After birth the tail samples of the pups were obtained for the purpose of genotyping to determine the transgenic founders. Fluorescence microscope and flow cytometer were used to measure the expression of CD69 on cells. RESULTS The construction of the expression vector pLCK-CD69-IRES-EGFP was verified by enzyme digestion and DNA sequencing. The transfected 293 T cell showed expression of the protein under fluorescence microscope. Identification of PCR for the tail tissue of the pups confirmed the present of CD69 transgene and resting lymphocytes demonstrated the expression of CD69. CONCLUSION The construction of expression vector pLCK-CD69-IRES-EGFP and generation of CD69 transgenic mice have been successfully processed, which lays a foundation of the solid pattern studies in inflammatory diseases.

Construction and functional analysis of a mouse secretory TIGIT lentiviral vector

Construction of the Adeno-Associated Virus Enhanced Plasmid of Murine IL-10 and Its Expression in Murine Cardiomycocytes

Generation and Characterization of Polyclonal Antibodies Against Mouse T-cell Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Domain by DNA-based Immunization.

[Expression, Purification and Identification of Fusion Protein Mtslpr-Ig].

Construction of mouse IL-10 recombinanted lentiviral vector and virus packaging

Supression of TGIF by shRNA mediated in novel inducible lentiviral vector modulates TGF-β signaling

Construction and expression of a single chain antibody variable fragment of agonist anti-CD40 antibody lentiviral vector

Construction of Eukaryotic Expression Plasmid of Murine TLR3 and Identification of Its Biological Activity

Construction and Verification of Lentivirus Vector Expressing Mouse Notch Intracellular Domain

Expression of LTβR-Ig Fusion Protein by Eukaryocytes and Evaluation of Its Bioactivity in Vitro

[Construction of Expression Vector Plck-Cd69-ires-egfp and Generation of CD69 Transgenic Mice].

Construction of Eukaryotic Expression Vector Containing Mouse IL-18 and Examination of the Bioactivity of the Expressed IL-18

Expression, purification and characterization of human inhibitory receptor TIGIT in E.coli

Construction of Eukaryotic Expression Vector of mOX40-hIgG1Fc

Construction of Eukaryotic Expressing Vector of Human TLT-2 and Establishment of Stable Transfectant L929 Cell Line

[Construction of a Recombinant Adenovirus Vector Harboring Human Transforming Growth Factor-Beta Type II Receptor-Igg1fc Fusion Gene].

[Study of the Construction and Function of an Eukaryotic Expression Plasmid of Immunotoxin DT390 Gene].

Construction of Eukaryotic Expression Vector of Mucd40-Igg1fc Fusion Protein and Its Expression in CHO Cells

Eukaryotic Expression and Characterization of Mouse TSLP and HIV-1 Gp120 BAL V1/V2 Fusion Protein

Construction of Plasmid Vector with Tat and the Study of Its Ability Transduct Fusion Protein into Cells

Construction, Expression and Immunogenicity Analysis of a Tat N-terminusdeleted Mutant Fusion Protein of Human Immunodeficiency Virus Type 1